Document Detail


The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects.
MedLine Citation:
PMID:  21745436     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mesolimbic dopamine system plays a critical role in the reinforcing effects of rewards. Evidence from pre-clinical studies suggests that D₃ receptor antagonists may attenuate the motivational impact of rewarding cues. In this study we examined the acute effects of the D₃ receptor antagonist GSK598809 on attentional bias to rewarding food cues in overweight to obese individuals (n=26, BMI mean=32.7±3.7, range 27-40 kg/m²) who reported binge and emotional eating. We also determined whether individual differences in restrained eating style modulated the effects of GSK598809 on attentional bias. The study utilized a randomized, double-blind, placebo-controlled cross-over design with each participant tested following acute administration of placebo and GSK598809 (175 mg). Attentional bias was assessed by the visual probe task and modified Stroop task using food-related words. Overall GSK598809 had no effects on attentional bias in either the visual probe or food Stroop tasks. However, the effect of GSK598809 on both visual probe and food Stroop attentional bias scores was inversely correlated with a measure of eating restraint allowing the identification of two subpopulations, low- and high-restrained eaters. Low-restrained eaters had a significant attentional bias towards food cues in both tasks under placebo, and this was attenuated by GSK598809. In contrast, high-restrained eaters showed no attentional bias to food cues following either placebo or GSK598809. These findings suggest that excessive attentional bias to food cues generated by individual differences in eating traits can be modulated by D₃ receptor antagonists, warranting further investigation with measures of eating behaviour and weight loss.
Authors:
Pradeep J Nathan; Barry V O'Neill; Karin Mogg; Brendan P Bradley; John Beaver; Massimo Bani; Emilio Merlo-Pich; Paul C Fletcher; Bridget Swirski; Annelize Koch; Chris M Dodds; Edward T Bullmore
Related Documents :
16257656 - Rapid pcr confirmation of e. coli o157:h7 after evanescent wave fiber optic biosensor d...
19064636 - Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic es...
9366606 - Maximizing the usefulness of food microbiology research.
8614696 - The effects of potassium sorbate and lactic acid on the shelf-life of vacuum-packed chi...
4436616 - Conjunctive schedules of reinforcement. i. rate-dependent effects of pentobarbital and ...
20922336 - Influence of the consumption of fruits and vegetables on the nutritional status of a gr...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2011-07-12
Journal Detail:
Title:  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)     Volume:  15     ISSN:  1469-5111     ISO Abbreviation:  Int. J. Neuropsychopharmacol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-02-21     Completed Date:  2012-09-27     Revised Date:  2014-02-24    
Medline Journal Info:
Nlm Unique ID:  9815893     Medline TA:  Int J Neuropsychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  149-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Attention / drug effects*
Cross-Over Studies
Cues*
Dopamine Antagonists / pharmacology*
Double-Blind Method
Feeding Behavior / drug effects*,  psychology
Female
Humans
Male
Middle Aged
Obesity / psychology*
Overweight / psychology*
Photic Stimulation / methods
Receptors, Dopamine D3 / antagonists & inhibitors*
Stroop Test
Treatment Outcome
Young Adult
Grant Support
ID/Acronym/Agency:
095692//Wellcome Trust
Chemical
Reg. No./Substance:
0/Dopamine Antagonists; 0/Receptors, Dopamine D3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Resolution Limits of Secondary Electron Dopant Contrast in Helium Ion and Scanning Electron Microsco...
Next Document:  Pilocarpine-induced temporal lobe epilepsy in the rat is associated with increased dopamine neuron a...